RADNOR,
Pa., May 15, 2023 /PRNewswire/ -- Avantor, Inc.
(NYSE: AVTR), a leading global provider of mission-critical
products and services to customers in the life sciences, advanced
technologies and applied materials industries, today announced that
Executive Vice President and Chief Financial Officer Thomas A. Szlosek will be leaving the Company
effective August 2, 2023 to pursue an
opportunity outside the life sciences industry. Mr. Szlosek will
continue in his role through the announcement of the Company's
second quarter earnings. Avantor has initiated a search to identify
the Company's next CFO.
"On behalf of the entire Avantor team, I thank Tom for all of
his contributions. He has been a great partner as we took Avantor
public in 2019, expanded the global enterprise, and built a
resilient foundation to drive growth in our core business," said
Michael Stubblefield, President and
Chief Executive Officer. "We appreciate Tom's dedication to Avantor
and his continued support to ensure a smooth transition."
Mr. Szlosek said, "It has been a privilege working alongside
such an exceptional team. With a strong foundation in place and
Avantor well positioned to continue capitalizing on fundamental
growth drivers and executing on its long-term strategy, I felt now
was the right time to take on a new opportunity."
The company reaffirmed the fiscal 2023 financial guidance
provided during the first quarter earnings conference call on
April 28, 2023.
About Avantor
Avantor®, a Fortune 500 company, is a leading global
provider of mission-critical products and services to customers in
the biopharma, healthcare, education & government, and advanced
technologies & applied materials industries. Our portfolio is
used in virtually every stage of the most important research,
development and production activities in the industries we serve.
Our global footprint enables us to serve more than 300,000 customer
locations and gives us extensive access to research laboratories
and scientists in more than 180 countries. We set science in motion
to create a better world. For more information, visit
avantorsciences.com and find us on LinkedIn, Twitter and
Facebook.
Forward-Looking and Cautionary Statements
This press
release contains forward-looking statements. All statements other
than statements of historical fact included in this press release
are forward-looking statements. Forward-looking statements discuss
our current expectations and projections relating to our financial
condition, results of operations, plans, objectives, future
performance and business.
Forward-looking statements are inherently subject to risks,
uncertainties and assumptions; they are not guarantees of
performance. You should not place undue reliance on these
statements. We have based these forward-looking statements on our
current expectations and projections about future events. Although
we believe that our assumptions made in connection with the
forward-looking statements are reasonable, we cannot assure you
that the assumptions and expectations will prove to be correct.
Factors that could contribute to these risks, uncertainties and
assumptions include, but are not limited to, the factors described
in "Risk Factors" in our most recent Annual Report on Form 10-K and
quarterly reports on Form 10-Q, as such risk factors may be updated
from time to time in our periodic filings with the SEC.
All forward-looking statements attributable to us or persons
acting on our behalf are expressly qualified in their entirety by
the foregoing cautionary statements. In addition, all
forward-looking statements speak only as of the date of this press
release. We undertake no obligations to update or revise publicly
any forward-looking statements, whether as a result of new
information, future events or otherwise other than as required
under the federal securities laws.
Avantor Investor Relations Contact
Christina Jones
Vice President, Investor Relations
805-617-5297
Christina.Jones@avantorsciences.com
Avantor Media Contact
Emily
Collins
Vice President, External Communications
332.239.3910
Emily.collins@avantorsciences.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/avantor-announces-cfo-transition-301824179.html
SOURCE Avantor and Financial News